Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
In second term, Mayor Q says he’ll help get City Hall out of entrepreneurs’ way as they build a more diverse economy
Creating economic equity in Kansas City goes hand in hand with building a sustainable city, said Mayor Quinton Lucas. “We will not be the city that we need to be — we won’t have the workforce, the entrepreneurs that we need — if we’re not actually investing in equitable tools in any number of ways,”…
Sandlot Goods takes a swing at a brick and mortar; new JoCo storefront expected to be a home run with brand’s fans
Sandlot Goods — Kansas City’s only local hat manufacturer — is hoping to score big with its first, dedicated, standalone retail space. The new location at Park Place in Leawood — 11530 Ash Street — is slated for a soft opening Aug. 15 and a grand opening Sept. 16, shared Garret Prather, Sandlot vice president…
‘Oppenheimer’ actor says new Missouri tax incentives could bring investors, more film productions to KC
David Dastmalchian’s screenplays for movies set in Kansas City now have a realistic chance to be filmed in and around his hometown, said the acclaimed actor, writer, and producer who grew up in Overland Park. Recently-signed legislation paves the way for increased film production in Missouri by reauthorizing — and strengthening — tax credit incentives…
She witnessed short-staffed hospitals as a COVID patient; How her ‘Airbnb for health care workers’ could save lives like hers
After her own hospitalization with COVID-19, Shapree’ Marshall set out to make sure local hospitals have adequate staffing to care for the community, she shared. In February 2022, Marshall — now a 2023 Pipeline Pathfinder cohort member — founded A Traveled Path Homes, which she describes as Airbnb for the medical industry. She plans to…